Search

everythinglearnresearchcommunity

for

Search:↓

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Enhancing cannabinoid signaling may help treat skin inflammation.

Bullous pyoderma gangrenosum can develop on cesarean scars and may require steroids for treatment.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Enzymes called PADIs play a key role in hair growth and loss.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Understanding how acne develops in different diseases could lead to new treatments.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Type I interferons play a key role in the development of various skin diseases.

White hair follicles in vitiligo have fewer and less functional melanocytes.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.